Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
statin |
| gptkbp:approvalYear |
2003
|
| gptkbp:ATCCode |
gptkb:C10AA08
|
| gptkbp:brand |
gptkb:Livazo
gptkb:Livalo Pitava |
| gptkbp:CASNumber |
147511-69-1
|
| gptkbp:contraindication |
pregnancy
lactation active liver disease |
| gptkbp:developer |
gptkb:Kowa_Pharmaceuticals
|
| gptkbp:drugClass |
lipid-lowering agent
|
| gptkbp:eliminationHalfLife |
11 hours
|
| gptkbp:excretion |
urine
feces |
| gptkbp:firstApproval |
gptkb:Japan
|
| gptkbp:hasMolecularFormula |
C50H46CaF2N2O8
|
| https://www.w3.org/2000/01/rdf-schema#label |
pitavastatin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
HMG-CoA reductase inhibitor
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
gptkb:X_(US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
myalgia
rhabdomyolysis liver enzyme elevation |
| gptkbp:synonym |
gptkb:NK-104
|
| gptkbp:usedFor |
gptkb:familial_hypercholesterolemia
dyslipidemia |
| gptkbp:bfsParent |
gptkb:Livalo
|
| gptkbp:bfsLayer |
7
|